Aptose Biosciences, Inc. - Common Shares (APTO) analyst actions
Rating and price-target actions on APTO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the APTO overview →
2 measured APTO analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Aptose Upgraded to Trade on OTCQB Market | Press release | — | — | |
| Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy | Press release | — | — |
Keep exploring
More APTO: earnings → · SEC filings → · APTO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NOVONESIS B UNSP/ADR (NVZMY) | 155 | +0.05% | 57% |
| PROMETIC LIFE SCIENCE (PFSCF) | 153 | 0.00% | 34% |
| MEI Pharma, Inc. (MEIP) | 152 | +0.07% | 51% |
| Milestone Scientific, Inc. (MLSS) | 152 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.